Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Fluence enters agreement to provide LED solutions for a Canadian LP's facility

Fluence by OSRAM will become the exclusive provider of LED lighting solutions for AgMedica BioScience, an Ontario-based licensed producer of cannabis for medicinal and adult-use consumers.

AgMedica will deploy Fluence’s LED systems in its world-class multitier facility with the capability to expand operations on demand. The facility will utilize Fluence’s SPYDR 2 series of LED systems at every stage of plant growth, from mother stock, propagation, vegetative to flowering, enabling AgMedica to grow crops consistently with high stability, while focusing on developing secondary metabolites—such as cannabinoids, terpenes and flavonoids—to produce medical cannabis unique to the company’s exacting standards.

“AgMedica prides itself on running a cutting-edge cultivation facility which produces consistent, quality medication for the health and well-being of all of our patients,” said Gregory Gawne, senior vice president of business development at AgMedica. “Fluence is a strategic partner which enables AgMedica to produce the highest-quality flowers and efficiently produce multiple times the amount of yield without expanding our physical real estate.”

Fluence SPYDR 2 series LED solutions are built for both multitier and single-tier applications and designed to deliver efficient, precise and uniform levels of photosynthetic photon flux density to increase plant yield.

“Fluence is proud to partner with AgMedica to develop the highest quality medical cannabis,” said Dave Cohen, chief executive officer at Fluence. “As demand increases around the world, AgMedica and other providers will be critical to ensuring consistent access to medical cannabis, cultivated with patients’ best interests in mind.”

For more information:
Fluence Bioengineering
4129 Commercial Center Drive
Suite 450
Austin, TX 78744
512-212-4544
info@fluencebioengineering.com 
fluence.science 

Publication date: